Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors

Journal of Neuroimmunology

Volumn 112, Issue 1-2, 2001, Pages 63-71

  Stangel, Martin ^a,b   Compston, Alastair ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

CNS inflammation; Immunomodulation; Intravenous immunoglobulins; IVIg; Microglia; Nitric oxide

Indexed keywords

ALPHA INTERFERON; FC RECEPTOR; GAMMA INTERFERON; GAMMAVENIN; IMMUNOGLOBULIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; IN VITRO STUDY; INFLAMMATORY DISEASE; MICROGLIA; NEWBORN; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOGLOBULINS, INTRAVENOUS; INTERFERON TYPE II; MICROGLIA; NITRIC OXIDE; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, FC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035209290     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00412-4     Document Type: Article

References (63)

1. Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor α secretion
2. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses
3. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages
4. Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo
5. Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-α activity in human immunodeficiency virus type 1 infection
6. Impairment of TNF-receptor-1 signaling but not Fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice
7. Apoptosis of T lymphocytes in acute disseminated encephalomyelitis
8. Stimulation of Fcg receptors in rat peritoneal macrophages induces the expression of nitric oxide synthase and chemokines by mechanisms showing different sensitivities to antioxidants and nitric oxide donors
9. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
10. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures
11. Phagocytosing ameboid microglial cells studied in a mouse corpus callosum slice preparation
12. Monocyte/macrophage differentiation in early multiple sclerosis lesions
13. A critical role for Syk in signal transduction and phagocytosis mediated by Fcg receptors on macrophages
14. Fc receptor biology
15. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Present status and practical therapeutic guidelines
16. Intravenous immunoglobulin modulates human mononuclear phagocyte tumor necrosis factor-α production in vitro
17. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions
18. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases
19. Nitric oxide and apoptosis: Another paradigm for the double-edged role of nitric oxide
20. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis
21. Human immunoglobulin ameliorates rat experimental autoimmune neuritis
22. Characterization of ameboid microglia isolated from developing mammalian brain
23. T-cell apoptosis in autoimmune diseases: Termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms
24. Microglia as mediators of inflammatory and degenerative diseases
25. Determination of nitrite/nitrate in human biological material by the simple Griess reaction
26. Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis
27. β-Interferon regulates the immunomodulatory activity of neonatal rodent microglia
28. A rapid and sensitive method allowing photometric determination of erythrophagocytosis by mononuclear phagocytes
29. Effect of IgG for intravenous use on Fc receptor-mediated phagocytosis by human monocytes
30. The Syk protein tyrosine kinase is essential for Fcg receptor signaling in macrophages and neutrophils
31. Nitric oxide in autoimmune disease: Cytotoxic or regulatory mediator?
32. Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells
33. Fc receptor-mediated signal transduction
34. Nitric oxide, a novel biologic messenger
35. Stimulation of the respiratory burst and promotion of bacterial killing in human granulocytes by intravenous immunoglobulin preparations
36. Effect of polymeric IgG on human monocyte functions
37. IFN-gamma receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide
38. Do antibodies stimulate myelin repair in multiple sclerosis?
39. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide
40. Apoptosis induction by macrophage-derived reactive oxygen species (ROS) in myelin-specific T cells requires cell-cell contact
41. Mechanisms of action of intravenous immune globulin in immune-mediated diseases
42. Immune complexes increase nitric oxide production by interferon-g-stimulated murine macrophage-like J774.16 cells
43. Synthesis of nitric oxide in CNS glial cells
44. Nitric oxide: Inducer or suppressor of apoptosis?
45. Patterns of oligodendroglia pathology in multiple sclerosis
46. The role of nitric oxide in multiple sclerosis
47. Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein
48. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis
49. Signal transduction by immunoglobulin Fc receptors
50. NO at work
51. 2+ movements and nitric oxide production in endothelial cells
52. Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis
53. Activation of microglia: A dangerous interlude in immune function in the brain
54. Indictment of the microglia as the villain in multiple sclerosis
55. Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases
56. A placebo-controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis
57. Oligodendroglia are protected from antibody mediated complement injury by normal immunoglobulins ('IVIg')
58. Normal polyclonal immunoglobulins ('IVIg') inhibit microglial phagocytosis in vitro
59. Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation
60. Human intravenous immunoglobulin (IVIG) preparations degranulate human neutrophils in vitro
61. In vitro inhibition of tumour necrosis factor-α and interleukin-6 production by intravenous immunoglobulins
62. The current place of high-dose immunoglobulins in the treatment of neuromuscular disorders
63. Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: A role for transforming growth factor β